• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3: New insider Atlas Merchant Capital Llc claimed ownership of 621,621 shares

    7/27/23 4:15:37 PM ET
    $ARTE
    Blank Checks
    Finance
    Get the next $ARTE alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Atlas Merchant Capital LLC

    (Last) (First) (Middle)
    477 MADISON AVENUE, 22ND FLOOR

    (Street)
    NEW YORK NY 10022

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    07/06/2023
    3. Issuer Name and Ticker or Trading Symbol
    Artemis Strategic Investment Corp [ ARTE ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Class A Common Stock 621,621 I See footnotes(1)(2)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The shares are held directly by Atlas Merchant Capital SPAC Fund I LP (the "Fund"). Atlas Merchant Capital LLC (the "Advisor") is a registered investment advisor and the investment manager of the Fund. Atlas Merchant Capital Holdings, Ltd. ("Holdings") is the managing member of the Advisor; Atlas Merchant Capital LP ("AMC Capital") is the sole voting shareholder of Holdings; and Atlas Merchant Capital GP LLC ("AMC-GP") is the general partner of AMC Capital. AMC SPAC Fund GP LP (the "General Partner") is the general partner of the Fund and AMC SPAC Fund MGP LLC ("AMC SPAC MGP") is the general partner of the General Partner. Robert E. Diamond and David I. Schamis are the sole members of AMC-GP and AMC SPAC MGP. (Con't in FN2)
    2. (Con't from FN1) Each of the Advisor, Holdings, AMC Capital, AMC-GP, the General Partner, AMC SPAC MGP and Messrs. Diamond and Shamis may be deemed to indirectly beneficially own the shares directly held by the Fund, but each of such persons disclaims such beneficial ownership except to the extent of its of his pecuniary interest in the shares held by the Fund.
    Atlas Merchant Capital LLC, By: /s/ David I. Schamis, Authorized Signatory 07/27/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ARTE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARTE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ARTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider Atlas Merchant Capital Llc claimed ownership of 621,621 shares

    3 - Artemis Strategic Investment Corp (0001839990) (Issuer)

    7/27/23 4:15:37 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Artemis Strategic Investment Corporation files Form S-4 in Connection with Its Business Combination with Danam Health, Inc.

    PHOENIX, AZ / ACCESSWIRE / September 18, 2023 / Artemis Strategic Investment Corporation (NASDAQ:ARTE), a publicly traded special purpose acquisition company ("Artemis"), today announced the filing of its registration statement on Form S-4 (the "Registration Statement") with the United States Securities and Exchange Commission ("SEC") in connection with Artemis' business combination with Danam Health, Inc. ("Danam"), a health services technology and pharmaceutical distribution company pioneering a healthcare ecosystem model designed to bring efficiency to the prescription journey and promote medication compliance.The Registration Statement contains a preliminary proxy statement and prospectu

    9/18/23 6:00:00 PM ET
    $ARTE
    Blank Checks
    Finance

    Danam Health, Inc. and Artemis Strategic Investment Corporation Announce the Execution of a Definitive Merger Agreement

    Danam Health, Inc. ("Danam") is a health services technology and pharmaceutical distribution company pioneering an ecosystem model designed to empower various stakeholders in the prescription journey and patient medication compliance aspects of healthcare.Founded by a consortium of top-tier pharma executives dedicated to improving the last mile of medication and healthcare delivery, Danam aims to achieve commercial success by utilizing advanced integrative technology to overcome both cost- and geography-related patient access barriers.Danam leverages its proprietary technology to bridge the gap that exists among patients, practitioners, pharmacies, and pharmaceutical product accessibility by

    8/7/23 8:05:00 AM ET
    $ARTE
    Blank Checks
    Finance

    Artemis Strategic Investment Corporation Announces Contribution to Trust Account in Connection with Proposed Extension; Clarifies that Trust Account Will Not Be Decreased Due to Excise Tax

    Phoenix, Arizona--(Newsfile Corp. - June 20, 2023) - Artemis Strategic Investment Corporation (NASDAQ:ARTEU) (NASDAQ:ARTE) (NASDAQ:ARTEW) (the "Company") announced today that it had filed a supplement ("Proxy Supplement") to its definitive proxy statement dated June 9, 2023 ("Proxy Statement") for the solicitation of proxies in connection with a special meeting of the Company's stockholders scheduled to be held on June 29, 2023 (the "Extension Meeting"), to consider and vote on, among other proposals, a proposal to extend the date by which the Company must consummate a business combination.The Proxy Supplement discloses that, if the Company's stockholders approve the proposed amendment to th

    6/20/23 4:15:00 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    SEC Filings

    View All

    SEC Form 15-12G filed by Artemis Strategic Investment Corporation

    15-12G - Artemis Strategic Investment Corp (0001839990) (Filer)

    11/13/23 1:33:49 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Artemis Strategic Investment Corporation

    25-NSE - Artemis Strategic Investment Corp (0001839990) (Subject)

    11/3/23 4:17:54 PM ET
    $ARTE
    Blank Checks
    Finance

    Artemis Strategic Investment Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (Amendment)

    8-K/A - Artemis Strategic Investment Corp (0001839990) (Filer)

    11/2/23 5:00:14 PM ET
    $ARTE
    Blank Checks
    Finance

    $ARTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/14/24 4:55:24 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/14/24 4:47:18 PM ET
    $ARTE
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Artemis Strategic Investment Corporation (Amendment)

    SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)

    2/9/24 11:59:40 AM ET
    $ARTE
    Blank Checks
    Finance